Year: 2020
Type: review
Abstract: The poor outcome of patients with non-surgically removable advanced hepatocellular carcinoma (HCC), the most frequent type of primary liver cancer, is mainly due to the high refractoriness of this aggressive tumor to classical chemotherapy. Novel pharmacological approaches based on the use of inhibitors of tyrosine kinases (TKIs), mainly sorafenib and regorafenib, have provided only a modest prolongation of the overall survival in these HCC patients. The present review is an update of the available information regarding our understanding of the molecular bases of mechanisms of chemoresistance (MOC) with a significant impact on the response of HCC to existing pharmacological tools, which include classical chemotherapeutic agents, TKIs and novel immune-sensitizing strategies. Many of the more than one hundred genes involved in seven MOC have been identified as potential biomarkers to predict the failure of treatment, as well as druggable targets to develop novel strategies aimed at increasing the sensitivity of HCC to pharmacological treatments.
Source: Cancers
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,324
Funders: Ministerio de Ciencia, Innovación y Universidades, Fundación Científica Asociación Española Contra el Cáncer, Consejería de Educación, Junta de Castilla y León, Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España, Junta de Castilla y León, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, European Regional Development Fund, European Social Fund
Awards: G212836150, Quimiorresistencia del adenocarcinoma gástrico: Caracterización de su huella genética y superación mediante edición genómica programada basada en CRISPR/Cas9., G2973466802, G3293287054, G4226265948, G5382326010, G6389441387, Interés pronóstico y terapéutico de las proteínas SLC y ABC en adenocarcinomas hepáticos y gastrointestinales, G7505454962, G814523509, G8289202400
OpenAlex ID: W3036726575
